Skip to main content

Table 1 Baseline characteristics of study participants

From: Sulphadoxine-pyrimethamine plus azithromycin for the prevention of low birthweight in Papua New Guinea: a randomised controlled trial

Characteristic

Control (SPCQ and placebo)

Intervention (SPAZ)

(n = 1,382)

(n = 1,393)

Age, years

24.5

[5.4]

24.4

[5.5]

Height, cm; n = 2,729

154.3

[6.0]

154.1

[5.8]

Body mass index, kg/m2; n = 2,721

22.8

[2.9]

22.8

[2.9]

Mid-upper arm circumference, cm; n = 2,714

23.9

[2.5]

24.0

[2.6]

Fundal height, cm; n = 2,771

21.1

[4.2]

21.0

[4.3]

Haemoglobin (Hb), g/dL; n = 2,650

9.7

[1.5]

9.7

[1.5]

Anaemia, Hb <11 g/dL

1,058/1,313

(80.6)

1,099/1,337

(82.2)

Syphilis

15/1,122

(1.3)

20/1,166

(1.7)

No. of previous pregnancies

    

0

681

(49.4)

709

(51.0)

1

292

(21.2)

279

(20.1)

≥2

406

(29.4)

403

(29.0)

Previous adverse pregnancy outcome

103/1,375

(7.5)

119/1,389

(8.6)

Used bed net before enrolment (2 wks)

    

Not used

322

(23.4)

347

(25.0)

Used, without insecticide

588

(42.7)

561

(40.4)

Used, insecticide treated

466

(33.9)

481

(34.6)

Given new bed net at enrolment

873/1,375

(63.5)

849/1,385

(61.3)

Used antimalarials in this pregnancy

146/1,340

(10.9)

161/1,366

(11.8)

Peripheral parasitaemia by microscopy

    

Any speciesa

100/1,376

(7.3)

104/1,390

(7.5)

Plasmodium falciparum

87

(6.3)

90

(6.5)

Plasmodium vivax

11

(0.8)

12

(0.9)

Smoker

249/1,380

(18.0)

275/1,392

(19.8)

Rural residence

844/1,375

(61.4)

876/1,389

(63.1)

Literate

1,223/1,376

(88.9)

1,248/1,391

(89.7)

Income-generating activity (woman)

728/1,304

(55.8)

729/1,326

(55.0)

Income-generating activity (partner)

939/1,358

(69.2)

947/1,378

(68.7)

Highlander parentage

99/1,380

(7.2)

78/1,393

(5.6)

  1. Data are mean [standard deviation], or number (%).
  2. aIncludes two P. malariae in the control, and one P. malariae, one P. ovale, and one mixed P. falciparum and P. ovale infections in the intervention group.